DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $972M
- YoY, 2025
- +54.3%
- 5-year CAGR
- +23.2%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $972M | +54.3% |
| 2024 | $630M | +589.9% |
| 2023 | $91M | −63.8% |
| 2022 | $252M | −31.5% |
| 2021 | $368M | +7.5% |
| 2020 | $342M | +2,339.2% |
| 2019 | $14M | — |